Patrin Pharma

Patrin Pharma is a private, commercial-stage generic drug company founded in 2018 and headquartered in San Diego, with significant operational facilities in the greater Chicago area. The company specializes in 'practical innovation' within niche generic markets, including complex formulations like oral solutions and topical products, often targeting controlled substances and first-to-market opportunities. It has a track record of FDA approvals, manages Paragraph IV challenges, and grows through strategic partnerships in development, manufacturing, and distribution. Its business model is fully commercial, generating revenue from its marketed products.

Efficient generic drug development and regulatory engine focused on 'practical innovation' for complex formulations (oral solutions, topicals, powders) and navigating Paragraph IV patent challenges.

Patrin competes with large generic conglomerates (Teva, Viatris, Sun Pharma) and numerous agile specialty generic companies. Its competitive edge lies in targeting small, complex niches that may be overlooked by larger players and in its demonstrated regulatory efficiency. Success depends on out-executing similar small-to-mid sized generic firms in product selection and development speed.